Chemoinformaics analysis of gamma-glutamyl-s-methylcysteine
| Molecular Weight | 264.303 | nRot | 8 |
| Heavy Atom Molecular Weight | 248.175 | nRig | 3 |
| Exact Molecular Weight | 264.078 | nRing | 0 |
| Solubility: LogS | -1.568 | nHRing | 0 |
| Solubility: LogP | -3.171 | No. of Aliphatic Rings | 0 |
| Acid Count | 2 | No. of Aromatic Rings | 0 |
| Base Count | 1 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 33 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 17 | No. of Aromatic Carbocycles | 0 |
| nHetero | 8 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 16 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 9 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 2 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 5 | No. of Arom Bond | 0 |
| nHA | 5 | APOL | 34.8087 |
| nHD | 4 | BPOL | 21.1153 |
| QED | 0.447 |
| Synth | 3.003 |
| Natural Product Likeliness | 0.409 |
| NR-PPAR-gamma | 0.028 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0 |
| Pgp-sub | 0.305 |
| HIA | 0.019 |
| CACO-2 | -6.4 |
| MDCK | 0.0000146 |
| BBB | 0.338 |
| PPB | 0.127574 |
| VDSS | 0.362 |
| FU | 0.805877 |
| CYP1A2-inh | 0.002 |
| CYP1A2-sub | 0.021 |
| CYP2c19-inh | 0.034 |
| CYP2c19-sub | 0.038 |
| CYP2c9-inh | 0.108 |
| CYP2c9-sub | 0.473 |
| CYP2d6-inh | 0.015 |
| CYP2d6-sub | 0.118 |
| CYP3a4-inh | 0.014 |
| CYP3a4-sub | 0.005 |
| CL | 3.004 |
| T12 | 0.761 |
| hERG | 0.009 |
| Ames | 0.017 |
| ROA | 0.005 |
| SkinSen | 0.136 |
| Carcinogencity | 0.042 |
| EI | 0.052 |
| Respiratory | 0.032 |
| NR-Aromatase | 0.004 |
| Antiviral | No |
| Prediction | 0.824294 |